You are here: Industry Insights > lupus

News List

CAR T-Cell Immunotherapy Rids Woman of Tough-to-Treat Lupus drugs
August 06, 2021
In a first, researchers have used genetically tweaked immune system cells to send a woman's severe lupus into remission.
Saphnelo Approved in US for Moderate to Severe Systemic Lupus Erythematosus americanpharmaceuticalreview
August 04, 2021
AstraZeneca’s Saphnelo (anifrolumab-fnia) has been approved in the US for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE) who are receiving standard therapy.
NICE turns down GSK's IV Benlysta for systemic lupus pharmatimes
June 04, 2021
The National Institute for Health and Care Excellence (NICE) has rejected NHS funding for an intravenous formulation of GlaxoSmithKline's Benlysta (belimumab) as an add-on therapy for certain patients with active autoantibody-positive systemic lupus.
Experimental Treatment Offers New Hope Against Lupus drugs
May 31, 2021
An experimental antibody therapy may help ease skin symptoms from the autoimmune disease lupus, a small preliminary trial suggests.
World Lupus Federation Global Survey of People with Lupus Finds Half of Respondents Experienced a Decrease in Access to Healthcare During COVID-19 Pandemic prnasia
April 26, 2021
In a new global survey, more than 6,100 people with lupus from over 85 countries shared their recent experiences of the COVID-19 pandemic and their views of the COVID-19 vaccines.
Frontline charities sign open letter backing COVID-19 vaccination drive pharmatimes
March 17, 2021
A partnership of frontline health charities has signed an open letter encouraging people with underlying conditions to book in for a COVID-19 vaccine.
Exagen, GSK Partner to Raise Lupus Diagnosis, Management Awareness americanpharmaceuticalreview
November 26, 2020
Exagen has extended its collaboration agreement with GlaxoSmithKline (GSK) to raise awareness of the importance of timely diagnosis of systemic lupus erythematosus (SLE), the most common and severe form of lupus.
PPD, Lupus Therapeutics to Support Lupus Clinical Research contractpharma
September 07, 2020
To provide enhanced protocol and trial optimization capabilities for its customers leveraging LT’s scientific, operational and drug development expertise.
How a Seattle Genetics cancer drug could help lupus patients fiercebiotech
April 13, 2020
The kidney is often a target of autoimmune diseases, including lupus. But little is known about how immune cells adapt to the low oxygen level in renal tissue to wreak havoc.
Affiliate of Lupus Research Alliance Developing Study Focused on Lupus Patients and COVID-19 americanpharmaceuticalreview
April 13, 2020
Lupus Therapeutics announced is embarking on a clinical study to assess the potential benefit of hydroxychloroquine and/or other lupus therapies in preventing or reducing the symptoms of COVID-19 in people with lupus.

Previous page 1 2 3 Next page